New ultrasound technologies bring amazing realism to ultrasound imaging
Los Angeles, CA. Monday September 19, 2011 -- GE Healthcare has announced today the availability of HDlive and Volume SRI (Speckle Reduction Imaging) for women's health imaging products within its Voluson Expert series platform. These innovations are being showcased for the first time in the United States at the 2011 International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) congress in Los Angeles.
* GE launches USD$100 million open innovation challenge globally to find and fund ideas to accelerate detection of breast cancer and enable more personalized treatment
* GE supports improved care delivery to 10 million patients around the world by 2020
* Previews revolutionary mobile mammography technology to enable access to screenings for women in rural and underserved areas
* GE to invest USD$1billion on cancer R&D over five years
Partners with INTER RAO UES and UEC in Energy, with RUSSIAN TECHNOLOGIES in Healthcare
GE expands presence in fast-growing Russian healthcare and energy markets
Anticipates orders of gas-fired power turbines with total capacity of up to 5 gigawatts of power as well as thousands of high-tech medical diagnostic units in Russia
NORWALK, CT-- September 16, 2011 --- GE Capital, Corporate Finance today announced it is co-syndication agent on a $600 million cash flow-based revolving credit facility for MasTec, Inc. (NYSE:MTZ), a leading infrastructure construction company. The financing will be used for growth and general corporate purposes. GE Capital Markets served as joint lead arranger and book manager.
$100 million open innovation challenge to find and fund ideas to accelerate detection of breast cancer and enable more personalised treatment
New mobile mammography concept SenoCase™ to transform access to screening in underserved areas
SenoBright™, an exclusive imaging technique, improves accuracy of breast exams and helps doctors better identify patients who need biopsies
GE to invest $1 billion on cancer R&D over five years
Formation of cancer coalition in Australia to expand access to mammography screening and breast cancer technology
